A PYMNTS Company

US: Icahn voices opposition to US$54b Cigna-Express Scripts deal

By  |  August 7, 2018

Carl Icahn went public Tuesday morning, August 7, with his campaign against Cigna’s US$54 billion plan to buy Express Scripts. The billionaire activist investor sent an open letter urging fellow Cigna shareholders to vote against the deal.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Icahn called the deal a “$60 billion folly” carrying a “ridiculous” price tag, according to a draft seen by The Wall Street Journal.

    CPI previously reported that Mr. Icahn bought a sizable Cigna stake, plans to vote against the health insurer’s proposed purchase of the pharmacy-benefit manager, and was considering publicly airing his concerns to persuade other shareholders to do the same.

    His concerns include competitive risk from Amazon and indications from the Trump administration that it could limit the manufacturer rebates pharmacy-benefit managers get.

    Full Content: The Wall Street Journal

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.